Stay updated on BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial
Sign up to get notified when there's something new on the BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial page.

Latest updates to the BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial page
- Check3 days agoChange DetectedThe page footer revision/version was updated from v3.5.2 to v3.5.3. This reflects a platform or release update rather than a change to the clinical study information.SummaryDifference0.0%

- Check10 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3, indicating a site version update.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This is a metadata/version change with no changes to study content or user-facing information.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision updated to v3.4.2; the older government-funding notice (v3.4.1) and its operating-status messaging were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check82 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and guidance to status updates. The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.2%

Stay in the know with updates to BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial page.